Safety and efficacy of a novel hepatobiliary MR contrast agent GN-1140 (Gd-DTPA-DeA): from the results of phase I and phase II clinical trials.
Tanimoto
Akihiro
A
Department of Diagnostic Radiology, Keio University School of Medicine, Tokyo, Japan.
Kadoya
Masumi
M
Kawamura
Yasutaka
Y
Kuwatsuru
Ryohei
R
Gokan
Takehiko
T
Hirohashi
Shinji
S
D000328:Adult; D000368:Aged; D003287:Contrast Media; D005260:Female; D019786:Gadolinium DTPA / Q000032:analysis*; D006801:Humans; D007275:Injections, Intravenous; D008099:Liver / Q000187:drug effects; D008113:Liver Neoplasms / Q000175:diagnosis*; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged
D003287:Contrast Media; D019786:Gadolinium DTPA